表紙:世界のPCOS治療の市場予測・競合動向・成長機会 (~2025年):手術区分・薬剤・診断法・エンドユーザー・地域別SALE
市場調査レポート
商品コード
979734

世界のPCOS治療の市場予測・競合動向・成長機会 (~2025年):手術区分・薬剤・診断法・エンドユーザー・地域別

Global PCOS Treatment Market, By Surgery, By Drug, By Diagnosis, By End User, By Region, Forecast & Opportunities, 2025

出版日: | 発行: TechSci Research | ページ情報: 英文 114 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.77円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

世界のPCOS治療の市場予測・競合動向・成長機会 (~2025年):手術区分・薬剤・診断法・エンドユーザー・地域別
出版日: 2021年01月01日
発行: TechSci Research
ページ情報: 英文 114 Pages
納期: 2-3営業日
担当者のコメント
2021年12月末までSingle User Licenseのディスカウントキャンペーンを実施中です。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の多嚢胞性卵巣症候群 (PCOS) 治療の市場規模は2019年の約33億9000万米ドルから、予測期間中は約8.63%のCAGRで成長すると予測されています。女性の糖尿病および肥満の増加、女性のホルモンバランスの乱れ、新薬および新しい治療オプションの開発などの要因が同市場の成長を推進する見通しです。

当レポートでは、世界の多嚢胞性卵巣症候群 (PCOS) 治療の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、世界および地域・国別の市場規模および市場シェアの推移・予測、手術区分・薬剤・診断法・エンドユーザーなど各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 製品の概要

第2章 調査手法

第3章 COVID-19の影響

第4章 顧客の声

第5章 エグゼクティブサマリー

第6章 世界市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 手術別
    • 卵巣楔状切除
    • 嚢胞吸引
    • 腹腔鏡下卵巣穿孔
  • 薬剤別
    • 排卵誘発剤
    • インスリン感作剤
    • 経口避妊薬
    • 抗アンドロゲン
    • 抗うつ剤
    • インスリン感作剤
    • 抗肥満薬
    • その他
  • 診断別
    • 骨盤検査
    • 超音波
    • 血液検査
  • エンドユーザー別
    • 病院・クリニック
    • 外来手術センター
    • 不妊治療クリニック
  • 企業別
  • 地域別
  • 製品市場マップ

第7章 アジア太平洋市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 手術別
  • 薬剤別
  • 診断別
  • エンドユーザー別
  • 国別
  • 国別分析

第8章 欧州市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 手術別
  • 薬剤別
  • 診断別
  • エンドユーザー別
  • 国別
  • 国別分析

第9章 北米市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 手術別
  • 薬剤別
  • 診断別
  • エンドユーザー別
  • 国別
  • 国別分析

第10章 南米市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 手術別
  • 薬剤別
  • 診断別
  • エンドユーザー別
  • 国別
  • 国別分析

第11章 中東・アフリカ市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 手術別
  • 薬剤別
  • 診断別
  • エンドユーザー別
  • 国別
  • 国別分析

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向

第14章 各種症状のための一般的なPCOS薬

第15章 競合情勢

  • Bristol-Myers Squibb Company
  • Bayer AG
  • Pfizer, Inc.
  • Abbott Laboratories, Inc.
  • Merck & Co., Inc.
  • Sanofi SA
  • AstraZeneca Plc
  • Novartis AG
  • Teva Pharmaceutical Industries Limited
  • Ferring Pharmaceuticals, Inc.

第16章 戦略的提言

第17章 当社について・免責事項

図表

List of Figures

1. Global PCOS Treatment Market, By Value, 2015-2025

2. Global PCOS Treatment Market Share, By Surgery, By Value, 2015-2025

3. Global PCOS Treatment Market Share, By Drug, By Value, 2015-2025

4. Global PCOS Treatment Market Share, By Diagnosis, By Value, 2015-2025

5. Global PCOS Treatment Market Share, By End User, By Value, 2015-2025

6. Global PCOS Treatment Market Share, By Company, By Value, 2015-2025

7. Global PCOS Treatment Market Share, By Region, By Value, 2015-2025

8. North America PCOS Treatment Market, By Value, 2015-2025

9. North America PCOS Treatment Market Share, By Surgery, By Value, 2015-2025

10. North America PCOS Treatment Market Share, By Drug, By Value, 2015-2025

11. North America PCOS Treatment Market Share, By Diagnosis, By Value, 2015-2025

12. North America PCOS Treatment Market Share, By End User, By Value, 2015-2025

13. North America PCOS Treatment Market Share, By Country, By Value, 2015-2025

14. Europe PCOS Treatment Market, By Value, 2015-2025

15. Europe PCOS Treatment Market Share, By Surgery, By Value, 2015-2025

16. Europe PCOS Treatment Market Share, By Drug, By Value, 2015-2025

17. Europe PCOS Treatment Market Share, By Diagnosis, By Value, 2015-2025

18. Europe PCOS Treatment Market Share, By End User, By Value, 2015-2025

19. Europe PCOS Treatment Market Share, By Country, By Value, 2015-2025

20. Asia Pacific PCOS Treatment Market, By Value, 2015-2025

21. Asia Pacific PCOS Treatment Market Share, By Surgery, By Value, 2015-2025

22. Asia Pacific PCOS Treatment Market Share, By Drug, By Value, 2015-2025

23. Asia Pacific PCOS Treatment Market Share, By Diagnosis, By Value, 2015-2025

24. Asia Pacific PCOS Treatment Market Share, By End User, By Value, 2015-2025

25. Asia Pacific PCOS Treatment Market Share, By Country, By Value, 2015-2025

26. MEA PCOS Treatment Market, By Value, 2015-2025

27. MEA PCOS Treatment Market Share, By Surgery, By Value, 2015-2025

28. MEA PCOS Treatment Market Share, By Drug, By Value, 2015-2025

29. MEA PCOS Treatment Market Share, By Diagnosis, By Value, 2015-2025

30. MEA PCOS Treatment Market Share, By End User, By Value, 2015-2025

31. MEA PCOS Treatment Market Share, By Country, By Value, 2015-2025

32. South America PCOS Treatment Market, By Value, 2015-2025

33. South America PCOS Treatment Market Share, By Surgery, By Value, 2015-2025

34. South America PCOS Treatment Market Share, By Drug, By Value, 2015-2025

35. South America PCOS Treatment Market Share, By Diagnosis, By Value, 2015-2025

36. South America PCOS Treatment Market Share, By End User, By Value, 2015-2025

37. South America PCOS Treatment Market Share, By Country, By Value, 2015-2025

List of Tables

1. Table 1: Drugs Used for controlling various symptoms of PCOS

目次
Product Code: 4683

Title:
Global PCOS Treatment Market, By Surgery (Ovarian Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian Drilling), By Drug (Ovulation Inducing Agents, Insulin-Sensitizing Agents, Oral Contraceptives, Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, Others), By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics), By Region, Forecast & Opportunities, 2025.

Global PCOS treatment market valued around USD 3.39 Billion in 2019 and is expected to grow at a formidable rate of around 8.63% during the forecast period. The global PCOS treatment market is driven by the increasing prevalence of diabetes and obesity among the woman population. Additionally, increasing cases of hormonal imbalances in the women are further expected to propel the market during forecast period. Furthermore, the development of new drugs and treatment options for the treatment of PCOS is expected to fuel the growth of market through 2025.

The global PCOS treatment market is segmented based on surgery, drug, diagnosis, end user, company and region. Based on surgery, the market can be categorized into ovarian wedge resection, cyst aspiration and laparoscopic ovarian drilling. The laparoscopic ovarian drilling segment is expected to dominate the market during forecast years. This can be attributed to the fertility problems faced by the women due to this problem and the response to medications generally weakens over time in women. Additionally, this procedure is cost effective and easy to perform which is driving the growth of segment across the globe.

Regionally, the global PCOS treatment market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, North America is expected to dominate the global PCOS treatment market owing to the growing prevalence of overweight and obese women population in the region.

Major players operating in the global PCOS treatment market include Bristol-Myers Squibb Company, Bayer AG, Pfizer, Inc., Abbott Laboratories, Inc., Merck & Co., Inc., Sanofi SA, AstraZeneca Plc, Novartis AG, Teva Pharmaceutical Industries Limited, Ferring Pharmaceuticals, Inc., and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and estimate the market size of global PCOS treatment market from 2015 to 2018.
  • To estimate and forecast the market size of global PCOS treatment market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global PCOS treatment market based on treatment, diagnosis, end user, company and regional distribution.
  • To identify dominant region or segment in the global PCOS treatment market.
  • To identify drivers and challenges for global PCOS treatment market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global PCOS treatment market.
  • To identify and analyze the profile of leading players operating in global PCOS treatment market.
  • To identify key sustainable strategies adopted by market players in global PCOS treatment market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals & clinics, ambulatory surgical centers, fertility clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals & clinics, ambulatory surgical centers, fertility clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals & clinics, ambulatory surgical centers, fertility clinics and presence of all major players across the globe.

TechSci Research calculated the market size of global PCOS treatment market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • PCOS treatment hospitals & clinics, ambulatory surgical centers, fertility centers and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to PCOS treatment
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals & clinics, ambulatory surgery centers, fertility clinics, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global PCOS treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global PCOS Treatment Market, By Surgery:
  • Laparoscopic Ovarian Drilling
  • Cyst Aspiration
  • Ovarian Wedge Resection
  • Global PCOS Treatment Market, By Drug:
  • Ovulation Inducing Agents
  • Insulin-Sensitizing Agents
  • Oral Contraceptives
  • Antiandrogens
  • Anti-Obesity Drugs
  • Anti-Depressants
  • Others
  • Global PCOS Treatment Market, By Diagnosis:

Pelvic Examination

Ultrasound

Blood Tests

  • Global PCOS Treatment Market, By End User:

Hospitals & Clinics

Ambulatory Surgical Centers

Fertility Clinics

  • Global PCOS Treatment Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global PCOS treatment market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global PCOS Treatment Market

4. Executive Summary

5. Voice of Customer

6. Global PCOS Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Surgery (Ovarian Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian Drilling)
    • 6.2.2. By Drug (Ovulation Inducing Agents, Insulin-Sensitizing Agents, Oral Contraceptives, Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, Others)
    • 6.2.3. By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests)
    • 6.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics)
    • 6.2.5. By Company (2019)
    • 6.2.6. By Region
  • 6.3. Product Market Map

7. Asia-Pacific PCOS Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Surgery
    • 7.2.2. By Drug
    • 7.2.3. By Diagnosis
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China PCOS Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Surgery
        • 7.3.1.2.2. By Drug
        • 7.3.1.2.3. By Diagnosis
        • 7.3.1.2.4. By End User
    • 7.3.2. India PCOS Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Surgery
        • 7.3.2.2.2. By Drug
        • 7.3.2.2.3. By Diagnosis
        • 7.3.2.2.4. By End User
    • 7.3.3. Australia PCOS Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Surgery
        • 7.3.3.2.2. By Drug
        • 7.3.3.2.3. By Diagnosis
        • 7.3.3.2.4. By End User
    • 7.3.4. Japan PCOS Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Surgery
        • 7.3.4.2.2. By Drug
        • 7.3.4.2.3. By Diagnosis
        • 7.3.4.2.4. By End User
    • 7.3.5. South Korea PCOS Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Surgery
        • 7.3.5.2.2. By Drug
        • 7.3.5.2.3. By Diagnosis
        • 7.3.5.2.4. By End User

8. Europe PCOS Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Surgery
    • 8.2.2. By Drug
    • 8.2.3. By Diagnosis
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France PCOS Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Surgery
        • 8.3.1.2.2. By Drug
        • 8.3.1.2.3. By Diagnosis
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany PCOS Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Surgery
        • 8.3.2.2.2. By Drug
        • 8.3.2.2.3. By Diagnosis
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom PCOS Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Surgery
        • 8.3.3.2.2. By Drug
        • 8.3.3.2.3. By Diagnosis
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy PCOS Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Surgery
        • 8.3.4.2.2. By Drug
        • 8.3.4.2.3. By Diagnosis
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain PCOS Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Surgery
        • 8.3.5.2.2. By Drug
        • 8.3.5.2.3. By Diagnosis
        • 8.3.5.2.4. By End User

9. North America PCOS Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Surgery
    • 9.2.2. By Drug
    • 9.2.3. By Diagnosis
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States PCOS Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Surgery
        • 9.3.1.2.2. By Drug
        • 9.3.1.2.3. By Diagnosis
        • 9.3.1.2.4. By End User
    • 9.3.2. Mexico PCOS Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Surgery
        • 9.3.2.2.2. By Drug
        • 9.3.2.2.3. By Diagnosis
        • 9.3.2.2.4. By End User
    • 9.3.3. Canada PCOS Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Surgery
        • 9.3.3.2.2. By Drug
        • 9.3.3.2.3. By Diagnosis
        • 9.3.3.2.4. By End User

10. South America PCOS Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Surgery
    • 10.2.2. By Drug
    • 10.2.3. By Diagnosis
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil PCOS Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Surgery
        • 10.3.1.2.2. By Drug
        • 10.3.1.2.3. By Diagnosis
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina PCOS Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Surgery
        • 10.3.2.2.2. By Drug
        • 10.3.2.2.3. By Diagnosis
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia PCOS Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Surgery
        • 10.3.3.2.2. By Drug
        • 10.3.3.2.3. By Diagnosis
        • 10.3.3.2.4. By End User

11. Middle East and Africa PCOS Treatment Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Surgery
    • 11.2.2. By Drug
    • 11.2.3. By Diagnosis
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa PCOS Treatment Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Surgery
        • 11.3.1.2.2. By Drug
        • 11.3.1.2.3. By Diagnosis
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia PCOS Treatment Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Surgery
        • 11.3.2.2.2. By Drug
        • 11.3.2.2.3. By Diagnosis
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE PCOS Treatment Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Surgery
        • 11.3.3.2.2. By Drug
        • 11.3.3.2.3. By Diagnosis
        • 11.3.3.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Commonly Used PCOS Drugs to control different symptoms

15. Competitive Landscape

  • 15.1. Bristol-Myers Squibb Company
  • 15.2. Bayer AG
  • 15.3. Pfizer, Inc.
  • 15.4. Abbott Laboratories, Inc.
  • 15.5. Merck & Co., Inc.
  • 15.6. Sanofi SA
  • 15.7. AstraZeneca Plc
  • 15.8. Novartis AG
  • 15.9. Teva Pharmaceutical Industries Limited
  • 15.10. Ferring Pharmaceuticals, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer